Evaluating the cost-effectiveness of afatinib after platinum-based therapy for the treatment of squamous non-small-cell lung cancer in France
Maud Pignata,1 Christos Chouaid,2 Katell Le Lay,3 Laura Luciani,3 Ceilidh McConnachie,4 James Gordon,5 Stéphane Roze1 1HEVA-HEOR, Lyon, 2Centre Hospitalier, Intercommunal de Créteil, Créteil, 3Boehringer Ingelheim, Paris, France; 4Ossian Health Economics and Communic...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-10-01
|
Series: | ClinicoEconomics and Outcomes Research |
Subjects: | |
Online Access: | https://www.dovepress.com/evaluating-the-cost-effectiveness-of-afatinib-after-platinum-based-the-peer-reviewed-article-CEOR |